How to investigate levels of Adherence to antiretroviral ... - INRUD
How to investigate levels of Adherence to antiretroviral ... - INRUD
How to investigate levels of Adherence to antiretroviral ... - INRUD
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
ANNEX 1: Facility interview results in detail<br />
Table 1:1. Facility data-1<br />
Facility<br />
1<br />
% ARVs Now<br />
in S<strong>to</strong>ck<br />
(Adult List)<br />
% ARVs Now<br />
in S<strong>to</strong>ck<br />
(Child List)<br />
% OI Key<br />
Medicines<br />
Now in S<strong>to</strong>ck<br />
Average %<br />
Days ARVs<br />
in S<strong>to</strong>ck<br />
(Adult List)<br />
Average %<br />
Days ARVs<br />
in S<strong>to</strong>ck<br />
(Child List)<br />
Average %<br />
Days OI Key<br />
Medicines in<br />
S<strong>to</strong>ck<br />
Weekly<br />
Number <strong>of</strong><br />
Patients<br />
Number <strong>of</strong><br />
Hours per<br />
Week<br />
Pts/ Hour/<br />
Clinician<br />
Pts/<br />
Week/<br />
Support staff<br />
# days<br />
supply <strong>of</strong><br />
ARVs given<br />
<strong>to</strong> new<br />
patients<br />
# days<br />
supply <strong>of</strong><br />
ARVs given<br />
<strong>to</strong> ongoing<br />
patients<br />
2<br />
3<br />
4<br />
5<br />
6<br />
7<br />
8<br />
9<br />
10<br />
11<br />
12<br />
13<br />
14<br />
15<br />
16<br />
17<br />
18<br />
19<br />
20<br />
Ave or %<br />
Maximum<br />
Median<br />
Minimum<br />
137
Change language